Please use this identifier to cite or link to this item:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Treatment of retinal degeneration

AuthorsCotter, Thomas G.; Doonan, Francesca; Sanvicens, Nuria CSIC; O'Driscoll, Carolyn; Messeguer Peypoch, Ángel CSIC ORCID
Issue Date11-Feb-2010
CitationWO2010016044 A1
AbstractThe use of a compound of general formula (I) : or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of a disease or condition characterised by apoptosis or degeneration of mammalian cells, wherein: R1 is a alkoxy, alkyl, ether or ester group; R2 is H or has the formula wherein Y is linear or branched, saturated or unsaturated, aliphatic group with from 2 to 23 carbon atoms, or a cyclic group, and which can contain substituents selected from the group consisting of hydroxyl, alkoxy, amino, carboxyl, cyano, nitro, alkylsuphonyl or halogen atoms, X is O or S; and R3 is any substituent.
Appears in Collections:(IQAC) Patentes

Files in This Item:
File Description SizeFormat
WO2010016044A1.pdf1,72 MBAdobe PDFThumbnail
Show full item record
Review this work

Page view(s)

checked on May 15, 2022


checked on May 15, 2022

Google ScholarTM


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.